{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-056751","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2025-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.636756+00:00","generated_at":"2026-05-16T13:23:01.093070+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"GRI Bio closes $8.0M public offering of common stock and Series F warrants","bullets":["Offering of 10,666,667 shares (or equivalents) plus Series F warrants to buy same number at $0.75/share.","Gross proceeds $8.0M; H.C. Wainwright acted as exclusive placement agent.","Series F warrants exercisable immediately at $0.75, expire in five years; potential additional $8.0M if fully cash-exercised.","Proceeds to fund product development, working capital, and general corporate purposes.","Post-offering stockholders' equity exceeds $2.5 million, addressing Nasdaq continued listing requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-056751","json":"https://secwatch.observer/filing/0001628280-25-056751.json","markdown":"https://secwatch.observer/filing/0001628280-25-056751.md","text":"https://secwatch.observer/filing/0001628280-25-056751.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/0001628280-25-056751-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/val-20251212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:23:01.093070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}